Patent ID: 8580258
Filing Date: 2013-11-12
Classification: A61K,A61N,A61P,C07K,G01N

Abstract:
1. A method for treating tumor cells or a tumor, wherein an antibody or an antigen-binding fragment thereof selected from the group consisting of i) an anti-L1CAM monoclonal antibody which binds to the same L1CAM epitope recognized by the monoclonal antibody 9.3, produced by the hybridoma cell deposited under DSMZ ACC2841, ii) an anti-L1CAM monoclonal antibody, wherein its six complementarity determining regions (CDRs) comprise iii) a monoclonal antibody, produced by the hybridoma cell deposited under DSMZ ACC2841; and iv) an antibody or antigen-binding fragment thereof comprising is administered to a subject in an effective amount to treat said tumor cells or tumor.